Financing,
A weak financing climate for Canadian public healthcare companies continued in the second quarter. Gross proceeds of completed equity and convertible debt financings amounted to $72.7 million (Appendix 1), bringing the total for the first half of 2010 to $308.7 million. Two issuers accounted for more than half of the activity in the second quarter: Aeterna Zentaris completed two equity financings totaling US$27.1 million and Resverlogix completed a $10 million financing.
Click here to view the entire report
